Abstract
EMA and the Heads of Medicines Agencies (HMA) have published their joint EU medicines agencies' network strategy to 2028 (EMANS), following its recent adoption by the HMA and the EMA Management Board. The strategy, titled 'Seizing opportunities in a changing medicines landscape', is a comprehensive update of the five-year strategy which was developed to cover the period 2021 to 2025 (EMANS 2025).
Key Data
-
Publication Date11 March 2025
-
Primary AuthorHeads of Medicines Agencies (HMA)
-
SourceHeads of Medicines Agencies (HMA)
-
LanguageEnglish
Click below to visit original source: